Additionally, we observed that STO-1 reprogrammed M2-type TAMs into the M1-type and further bolstered its anticancer activity by recruiting NK and T-cytotoxic (Tc) cells into the GBM tumor. Here, NCBP1 is linked to glioblastoma.